Back to Results
First PageMeta Content
Annual report / Financial statements / Willow / Income statement


Woburn Retirement System, et al. v. Salix Pharmaceuticals, Ltd., et al. 14-CV[removed]Complaint for Violation of the Federal Securities Laws
Add to Reading List

Document Date: 2014-11-16 13:56:57

Open Document

File Size: 1,05 MB

Share Result on Facebook

City

Raleigh / /

Company

Santarus Inc. / Woburn Massachusetts / Defendant Salix / VS. SALIX PHARMACEUTICALS LTD. / Salix Pharmaceuticals Ltd. / /

Currency

USD / /

Event

Conference Call / Judicial Event / M&A / Earnings Announcement / Company Listing Change / FDA Phase / /

Facility

Colonnade Center Drive / /

Holiday

Commonwealth Day / /

IndustryTerm

contributory retirement systems / pharmaceuticals and medical devices / improper accounting practices / media reports / pharmaceutical / consolidated registrant / interstate telephone communications / prescription drugs and medical devices / marketed products / /

MarketIndex

NASDAQ 100 / /

Organization

U.S. Securities and Exchange Commission / Digestive Disease Specialty Sales Force / /

Person

Derbyshire / YORK WOBURN / CAROLYN J. LOGAN / /

/

Position

Chief Financial Officer / care physician / certifying officer / executive offices / physician / wholesaler / undersigned counsel / Plaintiffs counsel / CEO / acting CFO / CFO and Executive Vice President / Finance and Administration / President and Chief Executive Officer / analyst / outside counsel / CFO / /

Product

XIFAXAN / XIFAXAN® (rifaximin) / /

ProvinceOrState

Delaware / North Carolina / Massachusetts / /

Technology

ADAM / prescription drugs and medical devices / /

SocialTag